Page last updated: 2024-10-16

anthranilic acid and Coma

anthranilic acid has been researched along with Coma in 1 studies

anthranilic acid: RN given refers to parent cpd; structure in Negwer, 5th ed, #565
anthranilic acid : An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.

Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.

Research Excerpts

ExcerptRelevanceReference
") or gavage administration of the KYN pathway blocking drug Ro 61-8048, both of which enter the brain from the circulatory system, affect the time to first convulsion and/or coma during HBO in a manner consistent with a modulatory role for seizure activity."3.70Evidence that kynurenine pathway metabolites mediate hyperbaric oxygen-induced convulsions. ( Amiridze, N; Brown, OR; Dale, WE; Dang, Y, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dale, WE1
Dang, Y1
Amiridze, N1
Brown, OR1

Other Studies

1 other study available for anthranilic acid and Coma

ArticleYear
Evidence that kynurenine pathway metabolites mediate hyperbaric oxygen-induced convulsions.
    Toxicology letters, 2000, Sep-30, Volume: 117, Issue:1-2

    Topics: Animals; Coma; Enzyme Inhibitors; Hyperbaric Oxygenation; Kynurenine; Kynurenine 3-Monooxygenase; Ma

2000